Paper404755
Mechanism of interferon action. Species specificity of interferon and of the interferon-mediated inhibitor of translation from mouse, monkey, and human cells.
Samuel CE and 1 other. Virology, 1977. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of interferon action. Species specificity of interferon and of the interferon-mediated inhibitor of translation from mouse, monkey, and human cells. Papers, record 404755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/404755
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism of interferon action. Species specificity of interferon and of the interferon-mediated inhibitor of translation from mouse, monkey, and human cells.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Protein Biosynthesis | Major topic |
| RNA, Messenger | Major topic |
| RNA, Viral | Major topic |
| Reoviridae | Major topic |
| Animals | |
| Cells, Cultured | |
| Fibroblasts | |
| Haplorhini | |
| Humans | |
| Methylation | |
| Mice | |
| Ribosomes | |
| Species Specificity | |
| Viral Proteins |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29187603 | Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29187603 | PubMed |
| 24307589 | Internal ribosome entry site-based attenuation of a flavivirus candidate vaccine and evaluation of the effect of beta interferon coexpression on vaccine properties. | J Virol | 2014 | https://conductscience.org/library/papers/24307589 | PubMed |
| 9623881 | The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. | Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9623881 | PubMed |
| 7565688 | Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7565688 | PubMed |
| 6156449 | Mechanism of interferon action: simian virus 40-specific early polypeptides synthesized in untreated and interferon-treated monkey kidney cells. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6156449 | PubMed |
| 284384 | Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284384 | PubMed |
| 222238 | Monkey interferon: activity on human cells and chromatographic properties. Brief report. | Arch Virol | 1979 | https://conductscience.org/library/papers/222238 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/404755
GET https://conductscience.org/api/papers/v1/404755/authors